Hyperfine, Inc. (NASDAQ:HYPR) Stock Has Consensus Target Price of $2.02 According to Brokerages

Shares of Hyperfine, Inc. (NASDAQ:HYPR) have received a consensus rating of “Moderate Buy” from the six analysts that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, three have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month target price among brokers that have covered the stock in the last year is $2.02.

Several analysts have recently weighed in on the stock. B. Riley Financial restated a “buy” rating and set a $1.60 price objective (down from $2.00) on shares of Hyperfine in a research report on Monday, August 10th. Lucid Cap Mkts assumed coverage on shares of Hyperfine in a research note on Tuesday, October 27th. They set a “strong-buy” rating on the stock. Wall Street Zen cut shares of Hyperfine from a “hold” rating to a “sell” rating in a research report on Saturday. Loop Capital set a $2.00 price objective on shares of Hyperfine in a research note on Tuesday. Finally, BTIG Research reiterated a “buy” rating and set a $2.00 target price on shares of Hyperfine in a research report on Tuesday, September 22nd.

Hyperfine Stock Performance

Shares of HYPR stock opened at $0.72 on Friday. Hyperfine has a 12 month low of $0.70 and a 12 month high of $1.94. The company has a current ratio of 6.15, a quick ratio of 5.45 and a debt-to-equity ratio of 0.36. The company has a market cap of $76.36 million, a P/E ratio of -1.89 and a beta of 1.45. The firm has a fifty day moving average price of $0.81 and a 200 day moving average price of $1.12.

Hyperfine (NASDAQ:HYPR) last released its quarterly earnings data on Thursday, August 6th. The company reported ($0.09) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.09). Hyperfine had a negative return on equity of 97.88% and a negative net margin of 210.75%. The business had revenue of $3.90 million during the quarter, compared to analysts’ expectations of $4.13 million. Sell-side analysts predict that Hyperfine will post -0.34 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Hyperfine

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Renaissance Technologies LLC raised its stake in Hyperfine by 100.2% during the 1st quarter. Renaissance Technologies LLC now owns 730,233 shares of the company’s stock valued at $789,000 after acquiring an additional 365,490 shares during the last quarter. Bank of New York Mellon Corp purchased a new position in shares of Hyperfine in the 2nd quarter valued at approximately $419,000. Walleye Capital LLC grew its stake in shares of Hyperfine by 3.4% in the 1st quarter. Walleye Capital LLC now owns 223,988 shares of the company’s stock valued at $242,000 after purchasing an additional 7,330 shares during the last quarter. Finally, PFS Partners LLC grew its stake in shares of Hyperfine by 150.0% in the 3rd quarter. PFS Partners LLC now owns 50,000 shares of the company’s stock valued at $40,000 after purchasing an additional 30,000 shares during the last quarter. Hedge funds and other institutional investors own 15.03% of the company’s stock.

About Hyperfine

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on making magnetic resonance imaging more accessible and convenient. The company develops portable, low-field MRI technology designed to bring brain imaging directly to patients in locations such as intensive care units, emergency departments, operating rooms and other point-of-care settings.

Hyperfine’s primary product is the Swoop Portable MR Imaging System, a compact MRI platform that can be moved to a patient’s bedside.